Archives for January 13, 2004

← 2004

Varying doses in coenzyme Q10 products, risk to consumer

Health professionals are being cautioned about the strength discrepancies of some Coenzyme Q10 products. Alternating brands of the popular CoQ10 supplement could hinder the management of diseases such as congestive heart failure and Parkinson's...

Canada raises consumer awareness of AR reporting

Canada's medicines body has released information on the adverse reactions caused by herbal medicines, in a reminder to health professionals and consumers of the procedure for reporting adverse events under the new Natural Health Products Regulations.

Progress on Parnuts amendments

Calcium sulphate as a source of calcium, and the amino acid salts, N-acetyl-L-cysteine and N-acetyl-L-methionine, may be included in draft regulations amending the PARNUTS directive, which will allow them to continue to be marketed for use in...

Parmalat crisis: the impact on ingredients firms

An emergency decree passed late last month by the Italian government in a bid to save dairy giant Parmalat from collapse looks set to win support from the European Commission on the back of guarantees that there will be no state bail-out for the company.

Second generation functional foods

European researchers have begun work on the first generation of tomato plants engineered to contain high quantities of flavonoids.

Vitamin D almost halves women's risk of MS

Women who take vitamin D supplements through multivitamins are 40 per cent less likely to develop multiple sclerosis (MS) than women who do not take supplements, shows a study published today.